Systemic lupus erythematosus (SLE) induced by biologics mostly occurs during the treatment of psoriasis with tumor necrosis factor-alpha (TNF-α) inhibitors, especially in patients with psoriatic and rheumatoid arthritis. Here, TNF is linked to psoriasis.